Progresses in synthetic vascular prostheses: Toward the endothelialization

Advances in Experimental Medicine and Biology

Volumn 534, Issue , 2003, Pages 165-177

  Crombez, Mathilde ^a   Mantovani, Diego ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; VASCULOTROPIN;

ANGIOGENESIS; BLOOD VESSEL PROSTHESIS; CELL MEMBRANE; CELL REGENERATION; HUMAN; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ADHESION; CELL ADHESION; CELL DIVISION; CYTOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

BLOOD VESSEL PROSTHESIS; CELL ADHESION; CELL DIVISION; ENDOTHELIUM, VASCULAR; HUMANS; SIGNAL TRANSDUCTION;

EID: 1542437593     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0063-6_13     Document Type: Review

References (61)

1. Szycher, M., 1991, Medical and Pharmaceutical Markets for Medical Plastics. In High Performance Biomaterials. Lancaster: Technomic Co, London, pp 1-25.
2. Guidoin, R., Chakfé, N., Maurel, S., How, T., Batt, M., Marois, M., and Gosselin, C., 1993, Expanded Polytetrafluoroethyene arterial prostheses in humans: Histopathological study of 298 surgically excised grafts. Biomaterials 14, 678-693.
3. Herring, M., Gardner, A., Peigh, P., Madison, D., Baughman, S., Brown, J., and Glover, J., 1984, Patency in canine inferior vena cava grafting: Effects of graft material, size, and endothelial seeding, J. Vasc. Surg. 1, 877-887.
4. Isner, J.M., and Takayuki, A., 1998, Therapeutic angiogenesis, Front. Biosci. 5, 49-69.
5. Jang, Y., Lincoff, A.M., Plow, E.F., and Topol, E.J., 1994, Cell adhesion molecules in coronary artery disease, J. Am. Coll. Cardiol. 24, 1591-1601.
6. Dejana, E., Languino, L.R., Colella, S., Corbascio, G.C., Plow, E., Ginsberg, M., and Marchisio, P.C., 1988, The localization of a platelet GpIIb-IIIa-related protein in endothelial cell adhesion structures, Blood 71, 566-572.
7. Lekatsas, J., and Koulouris, S., 2001, The role of selections in the development of coronary atherosclerosis, Hellenic J. Cardiol. (Athens) 42, 4-11.
8. Norgard-Sumnicht, K.E., Varki, N.M., and Varki, A., 1993, Calcium-dependent heparin-like ligands for L-selectin in nonlymphoid endothelial cells, Science 261, 480-483.
9. Koenig, A., Norgard-Sumnicht, K., Linhardt, R., and Varki, A., 1998, Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents, J. Clin. Invest. 101, 877-889.
10. White, H.D., 1997, Is heparin of value in the management of acute myocardial infarction?, Cardiovasc. Drugs Ther. 11, 111-119.
11. Giancotti, F.G., and Ruoslahti, E., 1999, Integrin signaling, Science 285, 1028-1032.
12. Beglova, N., Blacklow, S.C., Takagi, J., and Springer, T.A., 2002, Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation, Nat. Struct. Biol. 9, 282-287.
13. Hafdi, Z., Lesavre, P., Tharaux, P.L., Bessou, G., Baruch, D., and Halbwachs-Mecarelli, L., 1997, Role of alpha v integrins in mesangial cell adhesion to vitronectin and von Willebrand factor, Kidney Int. 51, 1900-1907.
14. Gimbrone, M.A. Jr., Nagel, T., and Topper, J.N., 1997, Biomechanical activation: An emerging paradigm in endothelial adhesion biology, J. Clin. Invest. 100, 61-65.
15. Shyy, J.Y., and Chien, S., 1997, Role of integrins in cellular responses to mechanical stress and adhesion, Curr. Opin. Cell. Biol. 9, 707-713.
16. Davies, P.F., Robotewskyj, A., and Griem, M.L., 1994, Quantitative studies of endothelial cell adhesion. Directional remodeling of focal adhesion sites in response to flow forces, J. Clin. Invest. 93, 2031-2038.
17. Maheshwari, G., Brown, G., Lauffenburger, D.A., Wells, A., and Griffith, L.G., 2000, Cell adhesion and motility depend on nanoscale RGD clustering, J. Cell. Sci. 113, 1677-1686.
18. Brooks, P.C., Clark, R.A., and Cheresh, D.A., 1994, Requirement of vascular integrin alpha v beta 3 for angiogenesis, Science 264, 569-571.
19. Jo, H., Sipos, K., Go, Y.M., Law, R., Rong, J., and McDonald, J.M., 1997, Differential effect of shear stress on extracellular signal-regulated kinase and N-terminal Jun kinase in endothelial cells, J. Biol. Chem. 272, 1395-1401.
20. Stromblad, S., and Cheresh, D.A., 1996, Integrins, angiogenesis and vascular cell survival, Chem. Biol. 3, 881-885.
21. Steed, D.L., 1997, The role of growth factors in wound healing, Surg. Clin. North Am. 77, 575-586.
22. Ishihara, M., Sato, M., Hattori, H., Saito, Y., Yura, H., Ono, K., Masuoka, K., Kikuchi, M., Fujikawa, K., and Kurita, A., 2001, Heparin-carrying polystyrene (HCPS)-bound collagen substratum to immobilize heparin-binding growth factors and to enhance cellular growth, J. Biomed. Mater. Res. 56, 536-544.
23. Ferrara, N, and Keyt, B., 1997, Vascular endothelial growth factor: Basic biology and clinical implications, Experimental Supplementum 79, 209-232.
24. Schlessinger, J., Lax, I., and Lemmon, M., 1995, Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors? Cell 83, 357-360.
25. Hamdan, A.D., Aiello, L.P., Misare, B.D., Contreras, M.A., King, G.L., LoGerfo, F.W., and Quist, W.C., 1997, Vascular endothelial growth factor expression in canine peripheral vein bypass grafts, J. Vasc. Surg. 26, 79-86.
26. Takeshita, S., Zheng, L.P., Brogi, E., Kearney, M., Pu, L.Q., Bunting, S., Ferrara, N., Symes, J.F., and Isner, J.M., 1994, Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model, J. Clin. Invest. 93, 662-670.
27. Sellke, F.W., Wang, S.Y., Friedman, M., Harada, K., Edelman, E.R., Grossman, W., and Simons, M., 1994, Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation, Am. J. Physiol. 267, 1303-1311.
28. Fuks, Z., Persaud, R.S., Alfieri, A., McLoughlin, M., Ehleiter, D., Schwartz, J.L., Seddon, A.P., Cordon-Cardo, C., and Haimovitz-Friedman, A., 1994, Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Canc. Res. 54, 2582-2590.
29. Spyridopoulos, I., Brogi, E., Kearney, M., Sullivan, A.B., Cetrulo, C., Isner, J.M., and Losordo, D.W., 1997, Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: Balance between growth and death signals, J. Mol. Cell Cardiol. 29, 1321-1330.
30. Brooks, P.C., Montgomery, A.M., Rosenfeld, M., Reisfeld, R.A., Hu, T., Klier, G., and Cheresh, D.A., 1994, Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels, Cell 79, 1157-1164.
31. Ferrara, N., and Davis-Smyth, T., 1997, The biology of vascular endothelial growth factor, Endocr. Rev. 18, 4-25.
32. Bikfalvi, A., Sauzeau, C., Moukadiri, H., Maclouf, J., Busso, N., Bryckaert, M., Plouet, J., and Tobelem, G., 1991, Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects, J. Cell. Physiol. 149, 50-59.
33. Bikfalvi, A., Dupuy, E., Inyang, A.L., Fayein, N., Leseche, G., Courtois, Y., and Tobelem, G., 1989, Binding, internalization, and degradation of basic fibroblast growth factor in human microvascular endothelial cells, Exp. Cell. Res. 181, 75-84.
34. Li, W., and Keller, G., 2000, VEGF nuclear accumulation correlates with phenotypical changes in endothelial cells, J. Cell. Sci. 113, 1525-1534.
35. Letourneur, D., Machy, D., Pelle, A., Marcon-Bachari, E., D'Angelo, G., Vogel, M., Chaubet, F., and Michel, J.B., 2002, Heparin and non-heparin-like dextrans differentially modulate endothelial cell proliferation: In vitro evaluation with soluble and crosslinked polysaccharide matrices, J. Biomed. Mater. Res. 60, 94-100.
36. Nikolaychik, V.V., Samet, M.M., and Lelkes, P.I., 1994, A new, cryoprecipitate based coating for improved endothelial cell attachment and growth on medical grade artificial surfaces, ASAIO J. 40, 846-852.
37. Lyman, D.J., Murray-Wijelath, J., Ambrad-Chalela, E., and Wijelath, E.S., 2001, Vascular graft healing. II. FTIR analysis of polyester graft samples from implanted bigrafts, J. Biomed. Mater. Res. 58, 221-237.
38. Williams, S.K., Jarrell, B.E., Friend, L., Radomski, J.S., Carabasi, R.A., Koolpe, E., Mueller, S.N., Thornton, S.C., Marinucci, T., and Levine, E., 1985, Adult human endothelial cell compatibility with prosthetic graft material, J. Surg. Res. 38, 618-629.
39. Seitz, T.L., Noonan, K.D., Hench, L.L., and Noonan, N.B., 1982, Effect of fibronectin on the adhesion of an established cell line to a surface reactive biomaterial, J. Biomed. Mater. Res. 16, 195-207.
40. Kesler, K.A., Herring, M.B., Arnold, M.P., Glover, J.L., Park, H.M., Helmus, M.N., and Bendick, P.J., 1986, Enhanced strength of endothelial attachment on polyester and polytetrafluoroethylene graft surfaces with fibronectin substrate, J. Vasc. Surg. 3, 58-64.
41. Lu, A., and Sipehia R., 2001, Antithrombotic and fibrinolytic system of human endothelial cells seeded on PTFE: The effects of surface modification of PTFE by ammonia plasma treatment and ECM protein coatings, Biomaterials 22, 1439-1446.
42. Tweden, K.S., Harasaki, H., Jones, M., Blevitt, J.M., Craig, W.S., Pierschbacher, M., and Helmus, M.N., 1995, Accelerated healing of cardiovascular textiles promoted by an ROD peptide, J. Heart Valve Dis. 4, 90-97.
43. Marchand-Brynaert, J., Detrait, E., Noiset, O., Boxus, T., Schneider, Y.J., and Remacle, C., 1999, Biological evaluation of RGD peptidomimetics, designed for the covalent derivatization of cell culture substrata, as potential promoters of cellular adhesion, Biomaterials 20, 1773-1782.
44. Pieper, J.S., Hafmans, T., Veerkamp, J.H., and van Kuppevelt, T.H., 2000, Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects, Biomaterials 21, 581-593.
45. Baumann, H., and Keller, R., 1997, Which glycosaminoglycans are suitable for antithrombogenic or athrombogenic coatings of biomaterials? Part II: Covalently immobilized endothelial cell surface heparan sulfate (ESHS) and heparin (HE) on synthetic polymers and results of animal experiments, Semin. Thromb. Hemost. 23, 215-223.
46. Bos, G.W., Scharenborg, N.M., Poot, A.A., Engbers, G.H., Beugeling, T., van Aken, W.G., and Feijen J., 1999, Blood compatibility of surfaces with immobilized albumin-heparin conjugate and effect of endothelial cell seeding on platelet adhesion, J. Biomed. Mater. Res. 47, 279-291.
47. Mann, B.K., and West, J.L., 2002, Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds, J. Biomed. Mater. Res. 60, 86-93.
48. Ito, Y., Chen, G., and Imanishi, Y., 1998, Artificial juxtacrine stimulation for tissue engineering, J. Biomater. Sci. Polym. Ed. 9, 879-890.
49. Stone, D., Phaneuf, M., Sivamurthy, N., LoGerfo, F.W., and Quist, W.C., 2002, A biologically active VEGF construct in vitro: implications for bioengineering-improved prosthetic vascular grafts, J. Biomed. Mater. Res. 59, 160-165.
50. Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J., and Holash, J., 2000, Vascular-specific growth factors and blood vessel formation, Nature 407, 242-248.
51. Doi, K., and Matsuda, T., 1997, Enhanced vascularization in a microporous polyurethane graft impregnated with basic fibroblast growth factor and heparin, J. Biomed. Mater. Res. 34, 361-370.
52. Tassiopoulos, A.K., and Greisler, H.P., 2000, Angiogenic mechanisms of endothelialization of cardiovascular implants: A review of recent investigative strategies, J. Biomater. Sci. Polym. Ed. 11, 1275-1284.
53. Elcin, Y.M., Dixit, V., and Gitnick, G., 2001, Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: Implications for tissue engineering and wound healing, Artif. Organs 25, 558-565.
54. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J., 2001, Polymeric system for dual growth factor delivery, Nature Biotechnol. 19, 1029-1034.
55. Sheridan, M.H., Shea, L.D., Peters, M.C., and Mooney, D.J., 2000, Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, J. Control Release 64, 91-102.
56. Masuda, S., Doi, K., Satoh, S., Oka, T., and Matsuda, T., 1997, Vascular endothelial growth factor enhances vascularization in microporous small caliber polyurethane grafts, ASAIO J. 43, 530-534.
57. Schneider, A., Melmed, R.N., Schwalb, H., Karck, M., Vlodavsky, I., and Uretzky, G., 1992, An improved method for endothelial cell seeding on polytetrafluoroethylene small caliber vascular grafts, J. Vasc. Surg. 15, 649-656.
58. Crombez, M., 2002, M.Sc. Thesis, Progresses in synthetic vascular prostheses: Toward the endothelialization. Laval University, Québec City, Canada.
59. Mantovani, D., Castonguay, M., Pageau, J.P., Fiset, M., and Laroche, G, 2000, Ammonia RF-Plasma Treatment of Tubular ePTFE Vascular Prostheses, Plasmas and Polymers, 4, 207-228;
60. Chevallier, P., Castonguay, M., Turgeon, S., Dubrulle, N., Mantovani, D., McBreen, P.H., Wittmann, J.C., and Laroche, G., 2001, Ammonia RF-plasma on PTFE surfaces: Chemical characterization of the species created on surface by vapor - phase chemical derivatization. J. Phys. Chem.B 105, 12490-12497.
61. Crombez, M., Chevallier, P., C-Gaudreault, R., Laroche, G., and Mantovani, D., 2002, Grafting of heparan sulfate/vascular endothelial growth factor complex onto synthetic substrates tq improve hemocompatibility, Proceeding of the Symposium on Advanced Materials for Biomedical Applications, D. Mantovani Ed., Canadian Institute of Mining, Metallurgy and Petroleum, pp. 49-66. (see also Badeau, M., et al. pp. 67-78 and Chevallier, P., et al. pp. 269-286).